New Botox Alternative 2025 Target. But now daxxify, a rival aesthetic injectable that was approved by the u.s food and drug administration (fda) on september 8, is set to knock it off its throne. It is in a family of aesthetic injectables known as neuromodulators, which include botox,.

8, is fda approved for temporary improvement of moderate to severe frown lines (formally called. It is in a family of aesthetic injectables known as neuromodulators, which include botox,.